BOI:EPA
Boiron SA
€18.60
arrow_upward
+0.54%(+0.10) 1D
Oct 29, 10:22:19 AM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€18.45
High
€18.70
Low
€18.45
Mkt. cap
326.34M
Avg. vol.
6.92K
Volume
613.00
P/E ratio
12.33
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
Open
€18.45
High
€18.70
Low
€18.45
Mkt. cap
326.34M
Avg. vol.
6.92K
Volume
613.00
P/E ratio
12.33
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
News stories
From web sources and news partners
FXStreet
·
1 hour ago
Dow Jones futures rise ahead of US PCE data
Trefis
·
21 minutes ago
The 52-Week-High List: 19 S&P 500 Names On Wednesday
Real Investment Advice
·
35 minutes ago
A Stealth Bear Market Hides Beneath A Flat S&P 500
TradingView
·
2 hours ago
SPX: S&P 500 Futures Slip After Google’s Earnings Spoil the Mood Globally
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA